Gomti Research And Pharmachem Profile
Key Indicators
- Authorised Capital ₹ 2.00 M
as on 23-10-2024
- Paid Up Capital ₹ 1.99 M
as on 23-10-2024
- Company Age 27 Year, 5 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 41.38 Cr
as on 23-10-2024
- Satisfied Charges ₹ 1.02 Cr
as on 23-10-2024
- Revenue 38.98%
(FY 2023)
- Profit 33.35%
(FY 2023)
- Ebitda 123.85%
(FY 2023)
- Net Worth 15.75%
(FY 2023)
- Total Assets 34.38%
(FY 2023)
About Gomti Research And Pharmachem
The Corporate was formerly known as Gomti Resins And Polymers Private Limited. The Company is engaged in the Chemicals And Materials Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 2.00 M and a paid-up capital of Rs 1.99 M.
The company currently has active open charges totaling ₹41.38 Cr. The company has closed loans amounting to ₹1.02 Cr, as per Ministry of Corporate Affairs (MCA) records.
Tulsiram Sharma, Manhori Devi, Rajendra Kumar, and Two other members serve as directors at the Company.
- CIN/LLPIN
U25110KA1997PTC022551
- Company No.
022551
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
21 Jul 1997
- Date of AGM
29 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Bangalore
Industry
Company Details
- Location
Bangaluru, Karnataka, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Gomti Research And Pharmachem?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Mahendra Sharma  | Managing Director | 21-Jul-1997 | Current |
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Tulsiram Sharma | Director | 21-Jul-1997 | Current |
| Manhori Devi | Director | 21-Jul-1997 | Current |
| Rajendra Kumar | Director | 21-Jul-1997 | Current |
| Panchariya Trupti | Director | 28-Apr-2022 | Current |
Financial Performance of Gomti Research And Pharmachem.
Gomti Research And Pharmachem Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 38.98% increase. The company also saw a substantial improvement in profitability, with a 33.35% increase in profit. The company's net worth Soared by an impressive increase of 15.75%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Gomti Research And Pharmachem?
In 2023, Gomti Research And Pharmachem had a promoter holding of 58.04% and a public holding of 41.96%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Gomti Life Sciences India Private LimitedActive 14 years 3 monthsTulsiram Sharma, Manhori Devi and 2 more are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Canara Bank Creation Date: 15 Dec 2023 | ₹1.10 Cr | Open |
Canara Bank Creation Date: 14 Dec 2023 | ₹3.00 Cr | Open |
Canara Bank Creation Date: 06 Jan 2021 | ₹12.12 Cr | Open |
How Many Employees Work at Gomti Research And Pharmachem?
Unlock and access historical data on people associated with Gomti Research And Pharmachem, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Gomti Research And Pharmachem, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Gomti Research And Pharmachem's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
